FDA Inspection 1241184 — ADMA BioCenters Georgia Inc
The FDA completed an inspection of ADMA BioCenters Georgia Inc on May 31, 2024 in Myrtle Beach, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 31, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Myrtle Beach, SC (United States)